
Newsletter – January 31st 2023
NEWSLETTER: What’s New In 2023: ExcitingPlans For Upperton Pharma Solutions! The New Year is always a time for looking ahead and 2023 will no doubt
Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
We offer our clients an extensive range of services, from early feasibility to dosage form development and clinical trial manufacturing.
Upperton’s formulation development team will confidently guide you on the best route forward.
Utilise our expertise and know-how to solve problems unique to your challenging molecule.
FIH through to phase II clinical
manufacturing. No project is too small or too challenging.
Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
NEWSLETTER: What’s New In 2023: ExcitingPlans For Upperton Pharma Solutions! The New Year is always a time for looking ahead and 2023 will no doubt
Senior QC Scientist/Senior Analytical Co-Ordinator
Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the formulation and spray drying of pharmaceutical and biotechnology products, providing a complete service from early-stage feasibility through to development and scale-up (including GMP clinical manufacture). Formulations cover a range of delivery routes, typically including oral (tablets & capsules), nasal and inhaled.
The Upperton laboratories and manufacturing plant are situated on the Science Park, adjacent to the University of Nottingham, and since obtaining an MHRA clinical trials manufacturing licence in 2019 we have experienced rapid, continuous growth across the whole business to continually satisfy our growing, international customer base.
As part of this expansion programme Upperton is looking to recruit a Senior Analytical Co-ordinator to join our Analytical Team.
Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facilityNottingham : 18th January 2023 Upperton Pharma Solutions, a leading UK contract development
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com